Showing results (221-230 of 1,297) with videos related to
Sort By:
Pageof 130
BMC Nephrology|January 17, 2018
Estimating the total prevalence and incidence of end-stage kidney disease among Aboriginal and non-Aboriginal populations in the Northern Territory of Australia, using multiple data sourcesLin Li, Steven Guthridge, Shu Qin Li, et al.Australian Health Review : a Publication of the Australian Hospital Association|May 30, 2017
Projecting demands for renal replacement therapy in the Northern Territory: a stochastic Markov modelJiqiong You, Yuejen Zhao, Paul Lawton, et al.The Medical Journal of Australia|August 1, 2002
Delayed referral to a nephrologist: outcomes among patients who survive at least one year on dialysisAlan Cass, Joan Cunningham, Peter C Arnold, et al.American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|February 2, 2010
Patient views about treatment of stage 5 CKD: a qualitative analysis of semistructured interviewsRachael L Morton, Jeannie Devitt, Kirsten Howard, et al.Diabetes & Vascular Disease Research|July 31, 2015
Dipeptidyl peptidase-4 inhibition with linagliptin and effects on hyperglycaemia and albuminuria in patients with type 2 diabetes and renal dysfunction: Rationale and design of the MARLINA-T2D™ trialPer-Henrik Groop, Mark E Cooper, Vlado Perkovic, et al.American Heart Journal|July 31, 2013
Rationale, design, and baseline characteristics of the Canagliflozin Cardiovascular Assessment Study (CANVAS)--a randomized placebo-controlled trialBruce Neal, Vlado Perkovic, Dick de Zeeuw, et al.American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|June 7, 2016
The Safety and Efficacy of Mineralocorticoid Receptor Antagonists in Patients Who Require Dialysis: A Systematic Review and Meta-analysisKevin Quach, Lyubov Lvtvyn, Colin Baigent, et al.Kidney International Reports|May 14, 2023
Targeting the Alternative Complement Pathway With Iptacopan to Treat IgA Nephropathy: Design and Rationale of the APPLAUSE-IgAN StudyDana V Rizk, Brad H Rovin, Hong Zhang, et al.Journal of the American Heart Association|December 2, 2021
Association Between Circulating GDF-15 and Cardio-Renal Outcomes and Effect of Canagliflozin: Results From the CANVAS TrialTaha Sen, Jingwei Li, Brendon L Neuen, et al.Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|June 19, 2026
Sex disparities in receiving evidence-based medications in patients with CKDRui Du, Hannah Wallace, Jeffrey T Ha, et al.Pageof 130